Literature DB >> 11960695

Contributions of Myc to tumorigenesis.

Werner Lutz1, Javier Leon, Martin Eilers.   

Abstract

Despite intensive research, the mechanisms by which deregulation of myc gene expression contributes to tumorigenesis are still not fully resolved and many aspects are still enigmatic. Several recent reviews, including one published in this series a few months ago, have summarized recent progress in our understanding of the biochemistry of Myc proteins [Eisenmann, Genes Dev. (2001) in press; Amati et al., Biochim. Biophys. Acta 1471 (2001) 135-145]. Also, the evidence documenting a central role of Myc proteins in human tumorigenesis has been extensively reviewed [Henriksson and Lüscher, Cancer Res. 68 (1996) 109-182]. In this article, we will argue that current progress allows us to present testable hypotheses on how Myc affects specific properties of transformed cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960695     DOI: 10.1016/s0304-419x(02)00036-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  57 in total

1.  Solution structure of a 2:1 quindoline-c-MYC G-quadruplex: insights into G-quadruplex-interactive small molecule drug design.

Authors:  Jixun Dai; Megan Carver; Laurence H Hurley; Danzhou Yang
Journal:  J Am Chem Soc       Date:  2011-10-14       Impact factor: 15.419

2.  Demonstration that drug-targeted down-regulation of MYC in non-Hodgkins lymphoma is directly mediated through the promoter G-quadruplex.

Authors:  Robert V Brown; Forest L Danford; Vijay Gokhale; Laurence H Hurley; Tracy A Brooks
Journal:  J Biol Chem       Date:  2011-09-28       Impact factor: 5.157

3.  Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance.

Authors:  Xiao-Ping Tan; Qing Zhang; Wei-Guo Dong; Xia-Wen Lei; Zi-Rong Yang
Journal:  Oncol Lett       Date:  2012-02-28       Impact factor: 2.967

4.  Cooperative action of multiple cis-acting elements is required for N-myc expression in branchial arches: specific contribution of GATA3.

Authors:  Eric Potvin; Laurent Beuret; Jean-François Cadrin-Girard; Marcelle Carter; Sophie Roy; Michel Tremblay; Jean Charron
Journal:  Mol Cell Biol       Date:  2010-09-20       Impact factor: 4.272

5.  Myc influences global chromatin structure.

Authors:  Paul S Knoepfler; Xiao-yong Zhang; Pei Feng Cheng; Philip R Gafken; Steven B McMahon; Robert N Eisenman
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

6.  c-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle.

Authors:  H Wang; S Mannava; V Grachtchouk; D Zhuang; M S Soengas; A V Gudkov; E V Prochownik; M A Nikiforov
Journal:  Oncogene       Date:  2007-10-01       Impact factor: 9.867

7.  c-Myc interacts with TRF1/PIN2 and regulates telomere length.

Authors:  Hongtae Kim; Junjie Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-08-22       Impact factor: 3.575

Review 8.  DNA secondary structures: stability and function of G-quadruplex structures.

Authors:  Matthew L Bochman; Katrin Paeschke; Virginia A Zakian
Journal:  Nat Rev Genet       Date:  2012-10-03       Impact factor: 53.242

9.  c-Myc-dependent formation of Robertsonian translocation chromosomes in mouse cells.

Authors:  Amanda Guffei; Zelda Lichtensztejn; Amanda Gonçalves Dos Santos Silva; Sherif F Louis; Andrea Caporali; Sabine Mai
Journal:  Neoplasia       Date:  2007-07       Impact factor: 5.715

Review 10.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.